Global Efficacy Testing Market Assessment, By Service Type [Antimicrobial/ Preservative Efficacy Testing, Disinfectant Efficacy Testing], By Application [Pharmaceutical Manufacturing, Cosmetics and Personal Care Products, Consumer Products, Medical Devices], By End-user [Pharmaceutical Companies, Laboratories, Research Institutes, Others], By Region, Opportunities and Forecast, 2017-2031F
The global efficacy testing market is expected to grow because of rising demand for novel drugs and therapeutics, rising geriatric population, government initiatives, and heavy investments made in the R&D.
Home>Industry Reports>Global Efficacy Testing Market Assessment, Opportunities and Forecast, 2017-2031F
Global efficacy testing market is projected to witness a CAGR of 7.34% during the forecast period 2024-2031, growing from USD 366.63 million in 2023 to USD 646.29 million in 2031. The expansion of the efficacy testing market is propelled by the advent of revolutionary, novel drugs and therapies. Regulations governing pharmaceutical and cosmetic products emphasize product safety, with a central focus on ensuring the efficacy of the active pharmaceutical ingredient (API). The marketplaces significance on regulatory compliance and validation of pharmaceutical products, incorporating diverse approaches such as preservative efficacy testing (PET). These methods have evolved over the years through collaboration among regulatory agencies, standards organizations, industry groups, and individual companies. The primary objective of these regulatory entities is to adhere to high documentation standards and scientific regulations. Significant investments are being made in emerging economies, driven by the untapped potential and substantial growth prospects in markets that are yet to be fully explored.
Strategies, such as partnerships, collaborations, agreements, and mergers and acquisitions, are taking place between different pharmaceutical companies, research institutes, and government support. In March 2022, PFNonwovens and Smart Plastic Technologies entered an exclusive joint development agreement to incorporate Smart Plastic's patent pending SPTek ECLIPSE technology into PFNonwovens' hygiene and medical nonwoven products. This agreement marked a step toward utilizing bio-assimilated materials in nonwovens for medical and hygiene applications, following thorough research and efficacy testing of the products.
In August 2022, Biocytogen Pharmaceuticals (Beijing) Co., Ltd. engaged in a global licensing arrangement with Merck to utilize Biocytogen's RenMice™ platform. As per the agreement, Merck gained complete access to Biocytogen's RenMice™ platform for the exploration and advancement of fully human antibody therapeutics across an extensive array of drug targets.
Rising Demand for Novel Drugs and Therapies
The global efficacy testing market is poised for growth, driven by the increasing demand for innovative drugs and therapies worldwide. This demand emerges from the increasing prevalence of chronic and infectious diseases like cancer, diabetes, tuberculosis, and heart diseases. The expanding geriatric population, often afflicted with chronic conditions, contributes to the increased demand for novel drugs and therapies. Government initiatives will improve healthcare infrastructure and fuel the growth of the pharmaceutical industry and efficacy testing market. Moreover, the rising incidence of genetic disorders and cancer is driving the demand for personalized drugs as well. Additionally, the varying susceptibility of individuals to infections and the inter-individual unpredictability in designing prognosis and treatments contribute to the growing need for personalized medicines. The substantial patient pool results in significant variations in individual behavior and bodily response, highlighting the demand for personalized medicines to enhance efficacy and, consequently, driving the demand for drug efficacy testing.
For instance, on July 26, 2023, the EU Commission published Regulation (EU) 2023/1545 amending Cosmetic Regulation (EC) 1223/2009 concerning allergens. This update includes new substances and revised restrictions on Cosmetic Product Labelling, expanding the number of allergens to be indicated in the INCI list of a finished cosmetic product if present at levels greater than 0.001% for leave-on products or 0.01% for rinse-off products.
Growing Adoption of Quality by Design (QbD) Approach
The healthcare sector is currently witnessing a notable trend as pharmaceutical and biotechnological companies increasingly embrace the quality by design (QbD) approach. This adoption stems from the critical emphasis on ensuring the stability and efficacy of drugs, both for patients and the companies. Many organizations are integrating the QbD approach to systematically identify, explain, and manage all sources of variability affecting a process, thereby safeguarding the quality of drugs. This ensures that the finished medicine consistently adheres to predefined performance characteristics right from the outset. Since the inception of QbD concepts, the industry has promptly embraced them to guarantee the quality of pharmaceutical and biotechnological products in compliance with regulatory requirements, employing approved research and development (R&D) and manufacturing procedures. Numerous quality requirements have been made mandatory for pharmaceutical or biotechnological products. The QbD approach has proven to be advantageous for pharmaceutical and biopharmaceutical companies, emphasizing that enhancing drug quality requires more than just increasing tests, thereby a proper R&D approach is indispensable.
A study in July 2023 highlighted that incorporating the Quality by Design (QbD) principle in the development of bilayer tablets will enhance product design and improve the quality, safety, and efficacy of drug products. According to the study, bilayer tablets have shown promising results for the development of fixed-dose combination (FDC) formulations.
Dominance of Pharmaceutical Manufacturing Applicants
The segment focusing on pharmaceutical manufacturing by application is poised for substantial growth in the forecast period. Clinical testing of drugs not only validates their performance and safety, but also enhances the credibility and authority of their packaging and marketing. The rising usage of drugs and vaccines contributes to an increased demand for efficacy testing, consequently propelling the growth of this segment. A considerable amount of testing and trials is required to give support to a newly developed drug throughout its manufacturing process. From discovery to development, and till the launch of a drug, a manufacturing company makes sure to pass its drug through many different phases and trials. Consequently, numerous companies are placing emphasis on efficacy testing for drugs in every phase. Efficacy testing, integral to drug research and development, verifies claims made on packaging or in marketing and ensures the intended use of the product. Preservative efficacy tests, crucial for confirming the safety of topical drugs for direct skin application, are also conducted. The mandatory regulation of these tests creates numerous opportunities for drug related efficacy testing.
Various countries are implementing rules and regulations to ensure compliance with claims made about drugs and vaccines. For example, Pfizer-BioNTech COVID-19 vaccine in May 2022, exhibited robust immune response, notable efficacy, and favorable safety in children aged 6 months to under 5 years after the administration of the third dose. The descriptive analysis revealed a vaccine efficacy of 80.3% during the period when the Omicron variant was predominant.
North America is Dominating the Global Efficacy Testing Market
Throughout the forecast period, North America is expected to lead the efficacy testing market, driven by factors such as increased research and development (R&D) activities and the widespread adoption of the quality by design (QbD) approach among regional market players. The pharmaceutical sector in North America is increasingly emphasizing outsourcing to contract research organizations (CROs) for drug development. Additionally, investments by government in contract development and manufacturing organizations (CDMO), drug substance, and drug product manufacturing capacities contribute to this dominance. The region boasts a well-established pharmaceutical industry, substantial R&D spending, a strong presence of major service providers, and a growing inclination among pharmaceutical and cosmetic companies to outsource analytical testing. According to OECD, in October 2022, pharmaceutical spending as a percentage of gross domestic product (GDP) was 2.08%, 1.72%, and 1.34% in the United States, Canada, and Mexico, respectively. This highlights the significant involvement of major players, manufacturers, and government organizations in product development, fostering demand for efficacy testing services and contributing to the overall growth of the examined market.
Future Market Scenario (2024 – 2031F)
Growth in demand of novel drugs and therapies to tackle numerous diseases presents the biggest opportunity for the efficacy testing market. Adoption of advanced and effective approaches have been devised to ensure the efficacy of APIs, which presents yet another opportunity in the market. R&D and heavy investments made by governments and healthcare companies is promoting developments in the efficacy testing market, and new labs and brands in this area of development are introducing advanced technologies, which, in turn, is propelling the market. For instance, SkinScience Analytics aims to transform the testing domain through its dedication to stringent scientific methodologies and commitment towards consumer welfare. Launched in August 2023 and based in Tucson, AZ, the lab specializes in various essential tests for product safety, encompassing the human repeat insult patch test (HRIPT), cumulative irritation testing, and safety-in-use evaluations.
Report Scope
“Global Efficacy Testing Market Assessment, Opportunities, and Forecast, 2017-2031F”, is a comprehensive report by Markets and Data, providing in-depth analysis and qualitative and quantitative assessment of the current state of the global efficacy testing market, industry dynamics, and challenges. The report includes market size, segmental shares, growth trends, opportunities, and forecast between 2024 and 2031. Additionally, the report profiles the leading players in the industry mentioning their respective market share, business model, competitive intelligence, etc.
|
Report Attribute |
Details |
|
Base Year of the Analysis |
2023 |
|
Historical Period |
2017-2022 |
|
Forecast Period |
2024-2031 |
|
Projected Growth Rate |
CAGR of 7.34% between 2024 and 2031 |
|
Revenue Forecast in 2031 |
USD 646.29 million |
|
Segments Covered |
Service Type, Application, End-user |
|
Regions Covered |
North America, Europe, South America, Asia-Pacific, Middle East and Africa |
|
Key Companies Profile |
Eurofins Viracor, River Laboratories International, Inc., Becton, Dickinson and Company, Société Générale de Surveillance, Merck KGaA, bioMérieux SA, Pacific Biolabs Inc, WuXi AppTec, North American Science Associates LLC, Accugen Laboratories, Inc. |
|
Customization Scope |
15% free report customization with purchase |
|
Pricing and Purchase Options |
Avail the customized purchase options to fulfill your precise research needs |
|
Delivery Format |
PDF and Excel through email (subject to the license purchased) |
In this report, the global efficacy testing market has been segmented into the following categories:
- By Service Type
- Antimicrobial/ Preservative Efficacy Testing
- Traditional Test Methods
- Rapid Test Methods
- Disinfectant Efficacy Testing
- Surface Test Methods
- Suspension Test Methods
- By Application
- Pharmaceutical Manufacturing
- Cosmetics and Personal Care Products
- Consumer Products
- Medical Devices
- By End-user
- Pharmaceutical Companies
- Laboratories
- Research Institutes
- Others
- By Region
- North America
- Europe
- Asia-Pacific
- South America
- Middle East and Africa
- Antimicrobial/ Preservative Efficacy Testing
Key Players Landscape and Outlook
Numerous companies, such as Eurofins Viracor, River Laboratories International, Inc., Becton, Dickinson and Company, Société Générale de Surveillance, Merck KGaA, bioMérieux SA, Pacific Biolabs Inc, WuXi AppTec, North American Science Associates LLC, Accugen Laboratories, Inc., etc., are directing their attention towards organic growth initiatives, including product launches, approvals, and endeavors like patents and events. Organic growth strategies observed in the market include acquisitions, partnerships, and collaborations. These initiatives have facilitated the expansion of business operations and the customer base for efficacy testing market players. Market players in the efficacy testing market are poised to encounter promising growth prospects in the global market. The primary focus of these leading players is directed towards the rapidly expanding market segment, aiming to thrive and excel in a competitive market environment. Additionally, these market players emphasize collaboration and license agreements as strategic initiatives that are anticipated to propel market growth.
In June 2022, SGS inaugurated a dedicated biosafety level-2 microbiological laboratory within its testing facility in Phoenix, Arizona. Occupying approximately 4,000 square feet within the 12,000-square-foot building, this new laboratory will specialize in conducting efficacy testing for hand sanitizer and antibacterial hand soap.
In June 2022, Eurofins Cosmetics & Personal Care acquired CRA Korea Inc., a clinical testing laboratory situated in South Korea. This laboratory predominantly specializes in delivering safety and efficacy studies, consumer tests and personal care industry.
Key Players Operating in the Global Efficacy Testing Market are:
- Eurofins Viracor
- River Laboratories International, Inc.
- Becton, Dickinson and Company
- Société Générale de Surveillance
- Merck KGaA
- bioMérieux SA
- Pacific Biolabs Inc
- WuXi AppTec
- North American Science Associates LLC
- Accugen Laboratories, Inc.
Markets and Data’s reports answer the following questions:
- What is the current and future market size of the product/service in question globally or specific to different countries?
- How are the markets divided into different product/service segments and the market size and growth of each segment?
- What is the market potential of different product segments and their investment case?
- How are the markets predicted to develop in the future and what factors will drive or inhibit growth?
- What is the business environment and regulatory landscape specific to the product/service?
If you can't find what you're searching for or have any custom requirements for the global efficacy testing market, you may approach our team at info@marketsandata.com.
Table of Contents
1. Research Methodology
2. Project Scope & Definitions
3. Executive Summary
4. Global Efficacy Testing Market Outlook, 2017-2031F
4.1. Market Size & Forecast
4.1.1.By Value
4.1.2.By Volume
4.2.1.Antimicrobial/ Preservative Efficacy Testing
4.2.1.1. Traditional Test Methods
4.2.1.2. Rapid Test Methods
4.2.2.Disinfectant Efficacy Testing
4.2.2.1. Surface Test Methods
4.2.2.2. Suspension Test Methods
4.3. By Application
4.3.1.Pharmaceutical Manufacturing
4.3.2.Cosmetics and Personal Care Products
4.3.3.Consumer Products
4.4. By End-user
4.4.1.Pharmaceutical Companies
4.4.2.Laboratories
4.4.3.Research Institutes
4.4.4.Others
4.5. By Region
4.5.1. North America
4.5.2. Europe
4.5.3. Asia-Pacific
4.5.4. South End-user America
4.5.5. Middle East and Africa
4.6. By Company Market Share (%), 2023
5. Global Efficacy Testing Market Outlook, By Region, 2017-2031F
5.1. North America*
5.1.1.Market Size & Forecast
5.1.1.1. By Value
5.1.1.2. By Volume
5.1.2.By Service Type
5.1.2.1. Antimicrobial/ Preservative Efficacy Testing
5.1.2.1.1. Traditional Test Methods
5.1.2.1.2. Rapid Test Methods
5.1.2.2. Disinfectant Efficacy Testing
5.1.2.2.1. Surface Test Methods
5.1.2.2.2. Suspension Test Methods
5.1.3.By Application
5.1.3.1. Pharmaceutical Manufacturing
5.1.3.2. Cosmetics and Personal Care Products
5.1.3.3. Consumer Products
5.1.3.4. Medical Devices
5.1.4.By End-user
5.1.4.1. Pharmaceutical Companies
5.1.4.2. Laboratories
5.1.4.3. Research Institutes
5.1.4.4. Others
5.1.5.United States*
5.1.5.1. Market Size & Forecast
5.1.5.1.1. By Value
5.1.5.1.2. By Volume
5.1.5.2. By Service Type
5.1.5.2.1. Antimicrobial/ Preservative Efficacy Testing
5.1.5.2.1.1. Traditional Test Methods
5.1.5.2.1.2. Rapid Test Methods
5.1.5.2.2. Disinfectant Efficacy Testing
5.1.5.2.2.1. Surface Test Methods
5.1.5.2.2.2. Suspension Test Methods
5.1.5.3. By Application
5.1.5.3.1. Pharmaceutical Manufacturing
5.1.5.3.2. Cosmetics and Personal Care Products
5.1.5.3.3. Consumer Products
5.1.5.3.4. Medical Devices
5.1.5.4. By End-user
5.1.5.4.1. Pharmaceutical Companies
5.1.5.4.2. Laboratories
5.1.5.4.3. Research Institutes
5.1.5.4.4. Others
5.1.6.Canada
5.1.7.Mexico
*All segments will be provided for all regions and countries covered
5.2. Europe
5.2.1.Germany
5.2.2.France
5.2.3.Italy
5.2.4.United Kingdom
5.2.5.Russia
5.2.6.Netherlands
5.2.7.Spain
5.2.8.Turkey
5.2.9.Poland
5.3. Asia-Pacific
5.3.1.India
5.3.2.China
5.3.3.Japan
5.3.4.Australia
5.3.5.Vietnam
5.3.6.South Korea
5.3.7.Indonesia
5.3.8.Philippines
5.4. South America
5.4.1.Brazil
5.4.2.Argentina
5.5. Middle East & Africa
5.5.1.Saudi Arabia
5.5.2.UAE
5.5.3.South Africa
6. Market Mapping, 2023
6.1. By Service Type
6.2. By Application
6.3. By End-user
6.4. By Region
7. Macro Environment and Industry Structure
7.1. Demand Supply Analysis
7.2. Import Export Analysis
7.3. Value Chain Analysis
7.4. PESTEL Analysis
7.4.1.Political Factors
7.4.2.Economic System
7.4.3.Social Implications
7.4.4.Technological Advancements
7.4.5.Environmental Impacts
7.4.6.Legal Compliances and Regulatory Policies (Statutory Bodies Included)
7.5. Porter’s Five Forces Analysis
7.5.1.Supplier Power
7.5.2.Buyer Power
7.5.3.Substitution Threat
7.5.4.Threat from New Entrant
7.5.5.Competitive Rivalry
8. Market Dynamics
8.1. Growth Drivers
8.2. Growth Inhibitors (Challenges and Restraints)
9. Regulatory Framework and Innovation
9.1. Patent Landscape
9.2. Innovations/Emerging Technologies
10. Key Players Landscape
10.1. Competition Matrix of Top Five Market Leaders
10.2. Market Revenue Analysis of Top Five Market Leaders (in %, 2023)
10.3. Mergers and Acquisitions/Joint Ventures (If Applicable)
10.4. SWOT Analysis (For Five Market Players)
10.5. Patent Analysis (If Applicable)
11. Pricing Analysis
12. Case Studies
13. Key Players Outlook
13.1. Eurofins Viracor
13.1.1. Company Details
13.1.2. Key Management Personnel
13.1.3. Products & Services
13.1.4. Financials (As reported)
13.1.5. Key Market Focus & Geographical Presence
13.1.6. Recent Developments
13.2. River Laboratories International, Inc.
13.3. Becton, Dickinson and Company
13.4. Société Générale de Surveillance
13.5. Merck KGaA
13.6. bioMérieux SA
13.7. Pacific Biolabs Inc
13.8. WuXi AppTec
13.9. North American Science Associates LLC
13.10. Accugen Laboratories, Inc.
*Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.
14. Strategic Recommendations
15. About Us & Disclaimer
List of Figures
Figure 1. Global Efficacy Testing Market, By Value, in USD Million, 2017-2031F
Figure 2. Global Efficacy Testing Market, By Volume, in Million Units, 2017-2031F
Figure 3. Global Efficacy Testing Market Share (%), By Service Type, 2017-2031F
Figure 4. Global Efficacy Testing Market Share (%), By Application, 2017-2031F
Figure 5. Global Efficacy Testing Market Share (%), By End-user, 2017-2031F
Figure 6. Global Efficacy Testing Market Share (%), By Region, 2017-2031F
Figure 7. North America Efficacy Testing Market, By Value, in USD Million, 2017-2031F
Figure 8. North America Efficacy Testing Market, By Volume, in Million Units, 2017-2031F
Figure 9. North America Efficacy Testing Market Share (%), By Service Type, 2017-2031F
Figure 10. North America Efficacy Testing Market Share (%), By Application, 2017-2031F
Figure 11. North America Efficacy Testing Market Share (%), By End-user, 2017-2031F
Figure 12. North America Efficacy Testing Market Share (%), By Country, 2017-2031F
Figure 13. United States Efficacy Testing Market, By Value, in USD Million, 2017-2031F
Figure 14. United States Efficacy Testing Market, By Volume, in Million Units, 2017-2031F
Figure 15. United States Efficacy Testing Market Share (%), By Service Type, 2017-2031F
Figure 16. United States Efficacy Testing Market Share (%), By Application, 2017-2031F
Figure 17. United States Efficacy Testing Market Share (%), By End-user, 2017-2031F
Figure 18. Canada Efficacy Testing Market, By Value, in USD Million, 2017-2031F
Figure 19. Canada Efficacy Testing Market, By Volume, in Million Units, 2017-2031F
Figure 20. Canada Efficacy Testing Market Share (%), By Service Type, 2017-2031F
Figure 21. Canada Efficacy Testing Market Share (%), By Application, 2017-2031F
Figure 22. Canada Efficacy Testing Market Share (%), By End-user, 2017-2031F
Figure 23. Mexico Efficacy Testing Market, By Value, in USD Million, 2017-2031F
Figure 24. Mexico Efficacy Testing Market, By Volume, in Million Units, 2017-2031F
Figure 25. Mexico Efficacy Testing Market Share (%), By Service Type, 2017-2031F
Figure 26. Mexico Efficacy Testing Market Share (%), By Application, 2017-2031F
Figure 27. Mexico Efficacy Testing Market Share (%), By End-user, 2017-2031F
Figure 28. Europe Efficacy Testing Market, By Value, in USD Million, 2017-2031F
Figure 29. Europe Efficacy Testing Market, By Volume, in Million Units, 2017-2031F
Figure 30. Europe Efficacy Testing Market Share (%), By Service Type, 2017-2031F
Figure 31. Europe Efficacy Testing Market Share (%), By Application, 2017-2031F
Figure 32. Europe Efficacy Testing Market Share (%), By End-user, 2017-2031F
Figure 33. Europe Efficacy Testing Market Share (%), By Country, 2017-2031F
Figure 34. Germany Efficacy Testing Market, By Value, in USD Million, 2017-2031F
Figure 35. Germany Efficacy Testing Market, By Volume, in Million Units, 2017-2031F
Figure 36. Germany Efficacy Testing Market Share (%), By Service Type, 2017-2031F
Figure 37. Germany Efficacy Testing Market Share (%), By Application, 2017-2031F
Figure 38. Germany Efficacy Testing Market Share (%), By End-user, 2017-2031F
Figure 39. France Efficacy Testing Market, By Value, in USD Million, 2017-2031F
Figure 40. France Efficacy Testing Market, By Volume, in Million Units, 2017-2031F
Figure 41. France Efficacy Testing Market Share (%), By Service Type, 2017-2031F
Figure 42. France Efficacy Testing Market Share (%), By Application, 2017-2031F
Figure 43. France Efficacy Testing Market Share (%), By End-user, 2017-2031F
Figure 44. Italy Efficacy Testing Market, By Value, in USD Million, 2017-2031F
Figure 45. Italy Efficacy Testing Market, By Volume, in Million Units, 2017-2031F
Figure 46. Italy Efficacy Testing Market Share (%), By Service Type, 2017-2031F
Figure 47. Italy Efficacy Testing Market Share (%), By Application, 2017-2031F
Figure 48. Italy Efficacy Testing Market Share (%), By End-user, 2017-2031F
Figure 49. United Kingdom Efficacy Testing Market, By Value, in USD Million, 2017-2031F
Figure 50. United Kingdom Efficacy Testing Market, By Volume, in Million Units, 2017-2031F
Figure 51. United Kingdom Efficacy Testing Market Share (%), By Service Type, 2017-2031F
Figure 52. United Kingdom Efficacy Testing Market Share (%), By Application, 2017-2031F
Figure 53. United Kingdom Efficacy Testing Market Share (%), By End-user, 2017-2031F
Figure 54. Russia Efficacy Testing Market, By Value, in USD Million, 2017-2031F
Figure 55. Russia Efficacy Testing Market, By Volume, in Million Units, 2017-2031F
Figure 56. Russia Efficacy Testing Market Share (%), By Service Type, 2017-2031F
Figure 57. Russia Efficacy Testing Market Share (%), By Application, 2017-2031F
Figure 58. Russia Efficacy Testing Market Share (%), By End-user, 2017-2031F
Figure 59. Netherlands Efficacy Testing Market, By Value, in USD Million, 2017-2031F
Figure 60. Netherlands Efficacy Testing Market, By Volume, in Million Units, 2017-2031F
Figure 61. Netherlands Efficacy Testing Market Share (%), By Service Type, 2017-2031F
Figure 62. Netherlands Efficacy Testing Market Share (%), By Application, 2017-2031F
Figure 63. Netherlands Efficacy Testing Market Share (%), By End-user, 2017-2031F
Figure 64. Spain Efficacy Testing Market, By Value, in USD Million, 2017-2031F
Figure 65. Spain Efficacy Testing Market, By Volume, in Million Units, 2017-2031F
Figure 66. Spain Efficacy Testing Market Share (%), By Service Type, 2017-2031F
Figure 67. Spain Efficacy Testing Market Share (%), By Application, 2017-2031F
Figure 68. Spain Efficacy Testing Market Share (%), By End-user, 2017-2031F
Figure 69. Turkey Efficacy Testing Market, By Value, in USD Million, 2017-2031F
Figure 70. Turkey Efficacy Testing Market, By Volume, in Million Units, 2017-2031F
Figure 71. Turkey Efficacy Testing Market Share (%), By Service Type, 2017-2031F
Figure 72. Turkey Efficacy Testing Market Share (%), By Application, 2017-2031F
Figure 73. Turkey Efficacy Testing Market Share (%), By End-user, 2017-2031F
Figure 74. Poland Efficacy Testing Market, By Value, in USD Million, 2017-2031F
Figure 75. Poland Efficacy Testing Market, By Volume, in Million Units, 2017-2031F
Figure 76. Poland Efficacy Testing Market Share (%), By Service Type, 2017-2031F
Figure 77. Poland Efficacy Testing Market Share (%), By Application, 2017-2031F
Figure 78. Poland Efficacy Testing Market Share (%), By End-user, 2017-2031F
Figure 79. South America Efficacy Testing Market, By Value, in USD Million, 2017-2031F
Figure 80. South America Efficacy Testing Market, By Volume, in Million Units, 2017-2031F
Figure 81. South America Efficacy Testing Market Share (%), By Service Type, 2017-2031F
Figure 82. South America Efficacy Testing Market Share (%), By Application, 2017-2031F
Figure 83. South America Efficacy Testing Market Share (%), By End-user, 2017-2031F
Figure 84. South America Efficacy Testing Market Share (%), By Country, 2017-2031F
Figure 85. Brazil Efficacy Testing Market, By Value, in USD Million, 2017-2031F
Figure 86. Brazil Efficacy Testing Market, By Volume, in Million Units, 2017-2031F
Figure 87. Brazil Efficacy Testing Market Share (%), By Service Type, 2017-2031F
Figure 88. Brazil Efficacy Testing Market Share (%), By Application, 2017-2031F
Figure 89. Brazil Efficacy Testing Market Share (%), By End-user, 2017-2031F
Figure 90. Argentina Efficacy Testing Market, By Value, in USD Million, 2017-2031F
Figure 91. Argentina Efficacy Testing Market, By Volume, in Million Units, 2017-2031F
Figure 92. Argentina Efficacy Testing Market Share (%), By Service Type, 2017-2031F
Figure 93. Argentina Efficacy Testing Market Share (%), By Application, 2017-2031F
Figure 94. Argentina Efficacy Testing Market Share (%), By End-user, 2017-2031F
Figure 95. Asia-Pacific Efficacy Testing Market, By Value, in USD Million, 2017-2031F
Figure 96. Asia-Pacific Efficacy Testing Market, By Volume, in Million Units, 2017-2031F
Figure 97. Asia-Pacific Efficacy Testing Market Share (%), By Service Type, 2017-2031F
Figure 98. Asia-Pacific Efficacy Testing Market Share (%), By Application, 2017-2031F
Figure 99. Asia-Pacific Efficacy Testing Market Share (%), By End-user, 2017-2031F
Figure 100. Asia-Pacific Efficacy Testing Market Share (%), By Country, 2017-2031F
Figure 101. India Efficacy Testing Market, By Value, in USD Million, 2017-2031F
Figure 102. India Efficacy Testing Market, By Volume, in Million Units, 2017-2031F
Figure 103. India Efficacy Testing Market Share (%), By Service Type, 2017-2031F
Figure 104. India Efficacy Testing Market Share (%), By Application, 2017-2031F
Figure 105. India Efficacy Testing Market Share (%), By End-user, 2017-2031F
Figure 106. China Efficacy Testing Market, By Value, in USD Million, 2017-2031F
Figure 107. China Efficacy Testing Market, By Volume, in Million Units, 2017-2031F
Figure 108. China Efficacy Testing Market Share (%), By Service Type, 2017-2031F
Figure 109. China Efficacy Testing Market Share (%), By Application, 2017-2031F
Figure 110. China Efficacy Testing Market Share (%), By End-user, 2017-2031F
Figure 111. Japan Efficacy Testing Market, By Value, in USD Million, 2017-2031F
Figure 112. Japan Efficacy Testing Market, By Volume, in Million Units, 2017-2031F
Figure 113. Japan Efficacy Testing Market Share (%), By Service Type, 2017-2031F
Figure 114. Japan Efficacy Testing Market Share (%), By Application, 2017-2031F
Figure 115. Japan Efficacy Testing Market Share (%), By End-user, 2017-2031F
Figure 116. Australia Efficacy Testing Market, By Value, in USD Million, 2017-2031F
Figure 117. Australia Efficacy Testing Market, By Volume, in Million Units, 2017-2031F
Figure 118. Australia Efficacy Testing Market Share (%), By Service Type, 2017-2031F
Figure 119. Australia Efficacy Testing Market Share (%), By Application, 2017-2031F
Figure 120. Australia Efficacy Testing Market Share (%), By End-user, 2017-2031F
Figure 121. Vietnam Efficacy Testing Market, By Value, in USD Million, 2017-2031F
Figure 122. Vietnam Efficacy Testing Market, By Volume, in Million Units, 2017-2031F
Figure 123. Vietnam Efficacy Testing Market Share (%), By Service Type, 2017-2031F
Figure 124. Vietnam Efficacy Testing Market Share (%), By Application, 2017-2031F
Figure 125. Vietnam Efficacy Testing Market Share (%), By End-user, 2017-2031F
Figure 126. South Korea Efficacy Testing Market, By Value, in USD Million, 2017-2031F
Figure 127. South Korea Efficacy Testing Market, By Volume, in Million Units, 2017-2031F
Figure 128. South Korea Efficacy Testing Market Share (%), By Service Type, 2017-2031F
Figure 129. South Korea Efficacy Testing Market Share (%), By Application, 2017-2031F
Figure 130. South Korea Efficacy Testing Market Share (%), By End-user, 2017-2031F
Figure 131. Indonesia Efficacy Testing Market, By Value, in USD Million, 2017-2031F
Figure 132. Indonesia Efficacy Testing Market, By Volume, in Million Units, 2017-2031F
Figure 133. Indonesia Efficacy Testing Market Share (%), By Service Type, 2017-2031F
Figure 134. Indonesia Efficacy Testing Market Share (%), By Application, 2017-2031F
Figure 135. Indonesia Efficacy Testing Market Share (%), By End-user, 2017-2031F
Figure 136. Philippines Efficacy Testing Market, By Value, in USD Million, 2017-2031F
Figure 137. Philippines Efficacy Testing Market, By Volume, in Million Units, 2017-2031F
Figure 138. Philippines Efficacy Testing Market Share (%), By Service Type, 2017-2031F
Figure 139. Philippines Efficacy Testing Market Share (%), By Application, 2017-2031F
Figure 140. Philippines Efficacy Testing Market Share (%), By End-user, 2017-2031F
Figure 141. Middle East & Africa Efficacy Testing Market, By Value, in USD Million, 2017-2031F
Figure 142. Middle East & Africa Efficacy Testing Market, By Volume, in Million Units, 2017-2031F
Figure 143. Middle East & Africa Efficacy Testing Market Share (%), By Service Type, 2017-2031F
Figure 144. Middle East & Africa Efficacy Testing Market Share (%), By Application, 2017-2031F
Figure 145. Middle East & Africa Efficacy Testing Market Share (%), By End-user, 2017-2031F
Figure 146. Middle East & Africa Efficacy Testing Market Share (%), By Country, 2017-2031F
Figure 147. Saudi Arabia Efficacy Testing Market, By Value, in USD Million, 2017-2031F
Figure 148. Saudi Arabia Efficacy Testing Market, By Volume, in Million Units, 2017-2031F
Figure 149. Saudi Arabia Efficacy Testing Market Share (%), By Service Type, 2017-2031F
Figure 150. Saudi Arabia Efficacy Testing Market Share (%), By Application, 2017-2031F
Figure 151. Saudi Arabia Efficacy Testing Market Share (%), By End-user, 2017-2031F
Figure 152. UAE Efficacy Testing Market, By Value, in USD Million, 2017-2031F
Figure 153. UAE Efficacy Testing Market, By Volume, in Million Units, 2017-2031F
Figure 154. UAE Efficacy Testing Market Share (%), By Service Type, 2017-2031F
Figure 155. UAE Efficacy Testing Market Share (%), By Application, 2017-2031F
Figure 156. UAE Efficacy Testing Market Share (%), By End-user, 2017-2031F
Figure 157. South Africa Efficacy Testing Market, By Value, in USD Million, 2017-2031F
Figure 158. South Africa Efficacy Testing Market, By Volume, in Million Units, 2017-2031F
Figure 159. South Africa Efficacy Testing Market Share (%), By Service Type, 2017-2031F
Figure 160. South Africa Efficacy Testing Market Share (%), By Application, 2017-2031F
Figure 161. South Africa Efficacy Testing Market Share (%), By End-user, 2017-2031F
Figure 162. By Service Type Map-Market Size (USD Million) & Growth Rate (%), 2023
Figure 163. By Application Map-Market Size (USD Million) & Growth Rate (%), 2023
Figure 164. By End-user Map-Market Size (USD Million) & Growth Rate (%), 2023
Figure 165. By Region Map-Market Size (USD Million) & Growth Rate (%), 2023
List of Tables
Table 1. Pricing Analysis of Products from Key Players
Table 2. Competition Matrix of Top 5 Market Leaders
Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
Table 4. About Us - Regions and Countries Where We Have Executed Client Projects
Frequently Asked Questions
What are the regions covered in the final report for the global efficacy testing market?
Who are the key players operating in the global efficacy testing market?
What are the major drivers influencing the growth of the global efficacy testing market?
What is the market size and growth rate of the global efficacy testing market?
See Related Reports
Global Compression Therapy Market Assessment, Opportunities and Forecast, 2017-2031F
Global compression therapy market is anticipated to witness significant growth over the forecast period owing to increasing investments by various companies towards novel product launches and the rise in the number of sports-related injuries.....Read More
Published on
July 2024
4,500
Global Liquid Biopsy Market Assessment, Opportunities and Forecast, 2017-2031F
Global liquid biopsy market is projected to experience significant growth over the forecast period owing to increasing preference for non-invasive diagnostic procedures and rising cases of cancer.....Read More
Published on
July 2024
4,500
Global Automotive Green Tires Market Assessment, Opportunities and Forecast, 2017-2031F
Global automotive green tire market is expected to experience growth due to rising demand for electric vehicles, rapid trend of personalization, stringent regulations for reducing carbon emissions, and advancement in tire technology.....Read More
Published on
July 2024
4,500
Global Automotive Bushing Market Assessment, Opportunities and Forecast, 2017-2031F
Global automotive bushing market is expected to experience growth due to rise in automotive production, a rapid shift toward electric vehicles, high demand for luxurious vehicles, and an increase in the production of automotive bushing. ....Read More
Published on
July 2024
4,500
Purchase Options
USD ($)
i
3,000
i
4,500
i
5,700
i
8,200
Tired of Searching?
Looking for Customization?
Some other doubt?
Need insights from a cohort?
REACH US
